POCT Lipids (Healthcheck)
EPTIS Ringversuch Nr. 142667 | Letze Änderung 2024-04-19 | URL: https://www.eptis.bam.de/pts142667 https://www.eptis.bam.de/pts142667
| Name des Anbieters | ||||||||||||||||
| Name des Anbieters | WEQAS Quality Laboratory WEQAS Quality Laboratory | |||||||||||||||
| Ansässig in | United Kingdom | |||||||||||||||
| Sprache(n) | ||||||||||||||||
| Anmerkungen | Human single donor blood is used as the matrix; however, donations with similar lipid concentrations of “off the clot” serum may be pooled. Participants can select to receive one sample monthly or bimonthly. The programme caters for the assessment of glucose as well as the Lipid Panel: cholesterol, HDL, and triglyceride. A range of serum samples are distributed over the year to cover the physiological and pathological range. The programme assesses the individual user, the organisation, and method performance, including, peer review of bias and imprecision. Periodically, a fresh whole blood sample is distributed to assess accuracy. Simple reports are available for the end user, and a more comprehensive report is available for the organisation’s coordinator. Key Features: Patient samples covering normal and pathological ranges. Human serum samples require no preparation, reducing risk of pre-analytical error. Additional assessment of accuracy using whole blood samples. Includes glucose. Simple reports. https://www.weqas.com/services/poct-eqa/poct-lipids/ | |||||||||||||||
| Klassifizierung | ||||||||||||||||
| Produktgruppen |
Health care / medical devices
Human test material |
|||||||||||||||
| Prüfgebiete |
Medical analysis
|
|||||||||||||||
| Technische Einzelheiten | ||||||||||||||||
|
||||||||||||||||
| Ringversuchsziele | ||||||||||||||||
| Zielgruppe des Ringversuchs | Lipid point of care testing analysers are used to screen and monitor patients with dyslipidaemia and as part of the NHS Health Check Programme in identifying individuals at risk of developing cardiovascular disease (CVD). Weqas Lipid POCT EQA programme provides material and EQA support for monitoring the performance and reliability of POCT Lipid devices in the NHS (both Primary and Secondary Care), Local authorities, Company Occupational Health Schemes, Pharmacies and Private healthcare providers. | |||||||||||||||
| Relevante Rechtsvorschriften oder Normen | Accreditation by UKAS on the basis of ISO/IEC 17025, 17043 and 15195 | |||||||||||||||
| Weitere Ziele | validation of testing methods | |||||||||||||||
| Teilnehmerzahl | ||||||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/ IEC 17043 |
|||||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||||||||
| Kosten | ||||||||||||||||
| Teilnahmegebühr | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||||||||
| Regelmässig durchgeführt | Ja (Monthly / Bi-monthly distribution of one set of samples ) | |||||||||||||||
| Der Ringversuch wird durchgeführt seit | 2006 | |||||||||||||||
| Kontaktdaten des Anbieters | ||||||||||||||||
| Anbieter | Kontaktperson | |||||||||||||||
|
WEQAS Quality Laboratory
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 747810 Fax: 44 (0) 2920 314760 Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 41287 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.